AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
An analysis of U.S. health claims reveals that while GLP-1 drugs like Wegovy may aid weight loss, they significantly increase medical costs—rising to $18,507 annually—without reducing obesity-related health events, raising concerns for insurers and employers.
The CDC confirms bird flu in two Washington poultry workers and ruled out infections in Missouri healthcare staff.
UK government has confirmed that disposable vapes will be banned from sale starting June 2025
Germany has detected its first case of the new mpox variant, clade 1b, in a 33-year-old man.
The World Health Organization reports 30,000 suspected mpox cases in Africa this year, with over 800 deaths, mostly in the Democratic Republic of Congo. The World Bank is allocating $128.89 million to support ten African countries in battling the outbreak.
You can download the AnewZ application from Play Store and the App Store.
